Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Thandi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cureus|May 8, 2026
A Tale of Two LADs (Left Anterior Descending Arteries): Type IV LAD as a Rare Coronary AnomalyPrashant Thandi, Ritesh Pandey
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|March 1, 2026
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatmentSajeet Verma, Akshyaya Pradhan, Prashant Thandi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|February 18, 2026
Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice!Prashant Thandi, Akshyaya Pradhan, Suresh Kumar Behera
The American Journal of Cardiology|March 5, 2026
``2025 ESC/EAS Dyslipidaemia Guidelines Focused Update: Intensifying Prevention, Risk Stratification, and Therapy"Akshyaya Pradhan, Prashant Thandi, Kunal Mahajan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cureus|May 8, 2026
A Tale of Two LADs (Left Anterior Descending Arteries): Type IV LAD as a Rare Coronary AnomalyPrashant Thandi, Ritesh Pandey
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|March 1, 2026
Zilebesiran: an RNA interference agent-its need and potential to transform hypertension treatmentSajeet Verma, Akshyaya Pradhan, Prashant Thandi
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|February 18, 2026
Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice!Prashant Thandi, Akshyaya Pradhan, Suresh Kumar Behera
The American Journal of Cardiology|March 5, 2026
``2025 ESC/EAS Dyslipidaemia Guidelines Focused Update: Intensifying Prevention, Risk Stratification, and Therapy"Akshyaya Pradhan, Prashant Thandi, Kunal Mahajan, et al.
Pageof 1